Sign Out
Ask the doctor or pharmacist for advice before taking any medicine.
Fludarabine treatment has the potential to harm the unborn child. The patient must not be given Fludalym if pregnant unless clearly necessary and when the potential benefits justify the potential risks to the unborn child. If the patient is a woman who may still be fertile, must avoid becoming pregnant during treatment and for at least 6 months after stopping treatment. However, if the patient does become pregnant inform the doctor immediately.
Men who are treated with Fludalym and can father a child must use a reliable form of contraception during, and for at least 6 months after stopping treatment.
It is not known if this medicine appears in the breast milk of women treated with Fludalym. However, in animal studies the medicinal product was found in breast milk. Therefore, the patient must not breast feed during treatment with this medicine.
